CDXS

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Total revenue 7.54 M15.33 M8.6 M38.91 M15.25 M14.91 M 77.68 M Gross profit 4.81 M13.23 M6.14 M36.87 M13.18 M11.4 M 67.59 M Operating expenses 28.03 M28.19 M25.09 M26.31 M21.23 M22.63 M 95.26 M Selling/general/admin expenses 12.36 M12.32 M11.22 M11.19 M9.78 M10.93 M 43.11 M Research & development 12.94 M13.78 M13.87 M11.72 M11.45 M11.71 M 48.74 M Operating income -20.49 M-12.86 M-18.95 M10.56 M-8.04 M-11.23 M -27.66 M Non-Operating Income, Total -191 K-400 K-658 K-939 K-625 K-766 K -2.99 M Interest expense, net of interest capitalized 281 K291 K357 K376 K376 K398 K 1.51 M Non-Operating Income, excl. Interest Expenses 470 K293 K277 K280 K289 K137 K 983 K Unusual income/expense -942 K-984 K-1.29 M-1.59 M-1.29 M-1.3 M -5.48 M Pretax income -20.68 M-13.26 M-19.61 M9.62 M-8.67 M-11.99 M -30.65 M Equity in earnings —————— — Taxes 11 K10 K8 00018 K36 K10 K 72 K Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -20.69 M-13.27 M-19.61 M9.6 M-8.7 M-12.01 M -30.72 M Discontinued operations —————— — Net income -20.69 M-13.27 M-19.61 M9.6 M-8.7 M-12.01 M -30.72 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -20.69 M-13.27 M-19.61 M9.6 M-8.7 M-12.01 M -30.72 M Basic earnings per share (Basic EPS) -0.25-0.16-0.220.13-0.1-0.13 -0.32 Diluted earnings per share (Diluted EPS) -0.25-0.16-0.220.13-0.1-0.13 -0.32 Average basic shares outstanding 82.41 M85.39 M90.25 M87.14 M90.77 M91.05 M — Diluted shares outstanding 82.41 M85.39 M90.25 M87.14 M90.77 M91.05 M — EBITDA -19.29 M-11.52 M-17.59 M11.91 M-6.76 M-10.02 M -22.45 M EBIT -20.49 M-12.86 M-18.95 M10.56 M-8.04 M-11.23 M -27.66 M Cost of revenue 2.73 M2.1 M2.46 M2.04 M2.06 M3.51 M 10.08 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 1.2 M1.34 M1.36 M1.36 M1.29 M1.21 M 5.21 M